Connecticut § 20-618 (Formerly Sec. 21a-107). Repackaged drugs not considered misbranded, when.

Connecticut Statutes

§ 20-618 — (Formerly Sec. 21a-107). Repackaged drugs not considered misbranded, when.

Connecticut·Title 20 Professional and Occupational Licensing, Certification, Title Protection and Registration. Examining Boards·Ch. 400j Pharmacy

Notwithstanding the provisions of section 21a-106 concerning misbranding of drugs or devices, a drug shall not be considered misbranded when repackaged by a pharmacy or an institutional pharmacy into stock packages for use within the pharmacy or the institutional pharmacy, provided the stock packages contain a label indicating the drug's name, strength, lot number, manufacturer and expiration date, if any.

Free access — add to your briefcase to read the full text and ask questions with AI

Notwithstanding the provisions of section 21a-106 concerning misbranding of drugs or devices, a drug shall not be considered misbranded when repackaged by a pharmacy or an institutional pharmacy into stock packages for use within the pharmacy or the institutional pharmacy, provided the stock packages contain a label indicating the drug's name, strength, lot number, manufacturer and expiration date, if any.

Connecticut § 20-618 ((Formerly Sec. 21a-107). Repackaged drugs not considered misbranded, when.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Legislative History

(P.A. 79-116, S. 2; P.A. 95-264, S. 39.) History: Sec. 19-226a transferred to Sec. 21a-107 in 1983; P.A. 95-264 made technical changes; Sec. 21a-107 transferred to Sec. 20-618 in 1997.